BioCentury

7:00 AM GMT, Apr 18, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Deals

Cellectar, Novelos deal

Cancer company Novelos acquired radiopharmaceutical company Cellectar in a stock deal valued at $64.4 million based on Novelos' close of

Read the full 202 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.